<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000045058"><TermName>2-methoxyestradiol</TermName><TermPronunciation>(2-meh-THOK-see-es-truh-DY-ol)</TermPronunciation><TermDefinition><DefinitionText>2ME2. A drug that prevents the formation of new blood vessels that tumors need in order to grow. It is derived from estrogen and belongs to the family of drugs called angiogenesis inhibitors.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000727453" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;2-methoxyestradiol&quot;" language="en" id="_3"/><MediaLink ref="CDR0000727454" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;2-metoxiestradiol&quot;" language="es" id="_4"/><SpanishTermName>2-metoxiestradiol</SpanishTermName><SpanishTermDefinition><DefinitionText>2ME2. Medicamento que previene la formación de nuevos vasos sanguíneos que los tumores necesitan para crecer. Se deriva del estrógeno y es un tipo de inhibidor de la angiogénesis.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2003-07-17</DateLastModified></GlossaryTerm>
